Humira (Hu-MARE-ah, adalimumab), a new biologic therapy for rheumatoid arthritis
Abbott is now introducing Humira (Hu-MARE-ah, adalimumab), a new biologic therapy for rheumatoid arthritis.
It's a tumor necrosis factor (TNF) blocking agent...similar to Remicade (infliximab) and Enbrel (etanercept).
Humira is for moderate to severe RA that's not controlled by methotrexate or other disease-modifying antirheumatic drugs.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote